Dec 13, 2005
Roche Files IND for Genmab Antibody

Dec 12, 2005
HuMax-CD20 Induces Rapid Responses in Relapsed CLL Patients

Dec 12, 2005
HuMax-CD38 Effective in Preclinical Studies

Dec 12, 2005
Genmab Announces Responses with HuMax-CD4™ in Non-Cutaneous T-Cell Lymphoma

Dec 2, 2005
Grant of Warrants in Genmab A/S

Dec 1, 2005
Capital Increase in Genmab as a Result of Employee Warrant Exercise

Dec 1, 2005
Genmab Announces Data on All Evaluable Patients in HuMax-CD20 NHL Phase I/II Study

Nov 8, 2005
Genmab Announces Results for the First Nine Months of 2005

Nov 4, 2005
Capital Increase in Genmab as a Result of Employee Warrant Exercise

Nov 3, 2005
Genmab Receives Patent for HuMax-HepC

Nov 1, 2005
Genmab Named Finalist for 2005 Scrip Awards

Nov 1, 2005
Data on HuMax-CD4 to be Presented at ASH

Oct 18, 2005
Genmab Among Europe's 500 Fastest Growing Companies

Oct 11, 2005
Genmab Nominated for the 2005 World Technology Award for Biotechnology

Oct 6, 2005
Genmab to Present HuMax-CD20 CLL Phase I/II Data at ASH

Sep 30, 2005
Genmab to Present at FT Global Pharmaceutical and Biotechnology Conference

Sep 30, 2005
Bo Kruse Appointed as CFO of Genmab A/S

Sep 26, 2005
Genmab to Present at UBS Global Life Sciences Conference

Sep 21, 2005
Grant of Warrants in Genmab A/S

Sep 15, 2005
Genmab Announces Positive Interim Results in Phase I/II HuMax-CD20 CLL Study

Aug 30, 2005
Capital Increase in Genmab as a Result of Employee Warrant Exercise

Aug 22, 2005
Genmab to Present Interim Results in Phase I/II HuMax®-CD20 CLL Study

Aug 18, 2005
Announcement of Additional Details Concerning Direct Placement of Genmab Shares to Serono

Aug 18, 2005
Serono and Genmab Announce Global Development and Commercialization Agreement for HuMax-CD4

Aug 16, 2005
Genmab Initiates HuMax®-CD20 Phase II Study in Rheumatoid Arthritis

Aug 10, 2005
Grant of Warrants in Genmab A/S

Aug 9, 2005
Genmab Announces 2005 First Half Year Results

Aug 5, 2005
Genmab Appoints Bo Kruse as Interim Chief Financial Officer

Aug 1, 2005
Capital Increase in Genmab as a Result of Employee Warrant Exercise

Jun 30, 2005
Genmab Acquires Worldwide Rights for HuMax-CD4

Jun 22, 2005
Capital Increase in Genmab as a Result of Employee Warrant Exercise

Jun 20, 2005
Genmab to Participate in Citigroup’s 2005 Biotechnology Forum

Jun 10, 2005
Genmab’s HuMax®-CD20 Induces Clinical Response in NHL at All Dose Levels

Jun 9, 2005
Genmab to Present at the Goldman Sachs 26th Annual Global Healthcare Conference

Jun 7, 2005
Grant of Warrants in Genmab A/S

Jun 6, 2005
Genmab Appoints Alberto Elli as Chief Financial Officer

Jun 2, 2005
HuMax®-CD20 Effective in Killing Tumor Cells with Very Low Levels of CD20

Jun 2, 2005
Genmab Appoints Vice President, Business Development

May 18, 2005
Genmab Acquires Rights for 16 Cancer Targets

May 13, 2005
Genmab Presents Additional HuMax®-EGFr Phase I/II Efficacy Data at ASCO Conference

May 12, 2005
Genmab Announces Multiple Myeloma Antibody Program

May 11, 2005
Capital Increase as a Result of Employee Warrant Exercise

May 10, 2005
Genmab Announces 2005 First Quarter Results

May 10, 2005
Interim Report 1st Quarter 2005

May 2, 2005
Serono and Genmab Sign Worldwide Agreement to Develop and Commercialize HuMax-TAC

Apr 20, 2005
Passing of Genmab A/S’ Annual General Meeting - Subsequent Grant of Warrants

Apr 20, 2005
Genmab Obtains Special Protocol Assessment Agreement for HuMax-CD4™ Pivotal Study

Mar 29, 2005
Genmab Completes Accrual in HuMax-CD20™ Phase I/II CLL Study

Mar 29, 2005
Genmab A/S Summons Annual General Meeting

Mar 22, 2005
Genmab to Present at 8th Annual Lehman Brothers’ Global Healthcare Conference

Mar 18, 2005
Genmab´s Annual Report 2004

Mar 11, 2005
Capital Increase in Genmab as a Result of Employees' Warrant Exercise

Feb 25, 2005
Genmab Wins Biotechnology’s Helix Award for Top Performance in 2004

Feb 21, 2005
Genmab’s CEO to Present at the BIO CEO & Investor Conference

Feb 18, 2005
HuMax-CD4™ Continues to Show Long Lasting Responses in T-cell Lymphoma Patients

Feb 9, 2005
Capital Increase in Genmab as a Result of Employee Warrant Exercise

Feb 8, 2005
Genmab Announces Year End 2004 Financial Results

Feb 8, 2005
Preliminary Annual Report 2004

Feb 1, 2005
Genmab to Present at 2005 Merrill Lynch Pharmaceutical, Biotechnology & Medical Device Conference

Jan 31, 2005
Dr. Lisa N. Drakeman Joins Board of Directors of Biotechnology Council of New Jersey

Jan 18, 2005
Genmab to Present at BioData 2005